The Battle Against Teen E-Cigarette Use.

Sep.07.2022
The Battle Against Teen E-Cigarette Use.
As the new school year approaches, educators and health experts strive to combat the increasing use of e-cigarettes among children in the US. Concerns over health and addiction risks continue to escalate. Initiatives include education, support, and regulation at multiple levels.

Over the past decade, an increasing number of children in the United States have been using electronic cigarettes.


Education professionals and health experts are making progress in the latest round of the fight against electronic cigarettes as the new school year begins.


Research on the health effects of e-cigarettes is continuing, but adverse effects are beginning to emerge.


Evidence suggests that teenagers who currently use e-cigarettes may turn to traditional smoking in the future, which is a troubling development in the significant progress made over the last few decades in reducing youth smoking. According to a scientific statement from the American Heart Association, those who use e-cigarettes may be at increased risk for asthma. Using e-cigarettes can also lead to respiratory diseases, arterial stiffness, high blood pressure, and difficulty sleeping. Even exposure to secondhand vapors from someone using e-cigarettes can pose a danger.


These concerns are even more complex in the environment of young people.


In a national survey conducted in 2021, nearly 60% of middle and high school students reported that they first tried electronic cigarettes because their friends used them. Friends are the most common way for teenagers to come into contact with e-cigarettes. Family members are another common source.


Helping children understand the risks of electronic cigarettes.


Jackie Michalski, Assistant Principal at Shenendehowa High School East in Clifton Park, New York, says that she has observed a decrease in the number of local teenagers using electronic cigarettes during the 2021-22 school year.


As people's understanding of it grows, it is sure to decrease," she said.


She and her colleagues have been promoting a continuous improvement mindset among students. The school organized an informational lecture for parents and students, with a focus on the potential health and psychological risks of using electronic cigarettes and other tobacco products.


During a recent meeting, local law enforcement officials advised parents to pay attention to changes in their children's attitudes or emotions, as well as how to detect signs of drug use in the home. Individuals who use electronic cigarettes may also experience increased thirst and nosebleeds, while parents may detect an unfamiliar odor they cannot identify, even if they have never seen the easily concealed products that do not produce smoke like traditional cigarettes.


Meanwhile, the response to students using electronic cigarettes on school grounds has shifted from punitive to supportive. While suspensions were once commonplace, educators now more frequently collaborate with parents, referring students to counselors and facilitating meetings with student groups, while helping to educate parents on effective strategies for addressing addiction and helping young people quit smoking. "Counselors are part of our team approach," Mihalski said.


Shenendehowa High School has implemented a program that involves students reading news articles and watching videos related to the use of e-cigarettes. Afterwards, they write a brief essay discussing what they have learned and how to better handle peer pressure.


The ultimate goal is to change behavior," said Mihalski. "We want to inform students that electronic cigarettes have a significant impact on health, they can lead to addiction and may result in future use of other drugs.


Extensive initiative


Changing behavior is also one of the targets of several national anti-e-cigarette initiatives, which have had an impact on research so far. These include:


SmokeSCREEN, a video game designed by researchers at Yale University, aims to educate children on the dangers of e-cigarettes and other tobacco products with the goal of helping them completely avoid using e-cigarettes. This is Quitting, developed by the public health non-profit organization Truth Initiative, sends daily automated text messages from peers who have tried or successfully quit using e-cigarettes to individuals aged 13 to 24. CATCH My Breath, developed by the Texas A&M Health Science Center in Houston, provides parental education and classroom curriculum, including group discussions, goal setting, and group activities. A digital portal offers materials for schools, some of which are free, including teaching guides, presentations, and posters designed for different age groups. Additionally, the FDA has partnered with a publishing company to create a series of anti-e-cigarette informational resources for educators.


The Boston University, funded by the American Heart Association, has a center dedicated to preventing the surge of teenage e-cigarette use. One of the projects under this center is focused on developing and testing virtual reality interventions to help high school students avoid or quit e-cigarettes. Lead researcher Belinda Borrelli and her team have collaborated extensively with high school students to understand their views on current smoking cessation programs and to design engaging and effective new programs. The team is using their data to develop state-of-the-art virtual reality interventions for implementation in schools.


She stated that "it's important that the intervention doesn't feel 'school-like', and regardless of their motivations to quit smoking, teenagers must be involved.


The efforts of parents, educators, advocates, and public health officials against the use of electronic cigarettes seemed to gain momentum in June when the FDA ordered Juul Labs to cease sales and distribution of their products due to a lack of data regarding potential health risks. This action has been temporarily halted in both administrative and legal proceedings.


Michalski stated that if the popular Juul product among teenagers were to be ultimately removed from the market, it would be encouraging news. "If we can make e-cigarettes less easily accessible, I think it will be helpful.


Dr. Naomi Hamburg, the chief researcher and director of the BU Youth Electronic Cigarette Research Center, stated that strict regulation at the federal, state, and community levels is a crucial tool for reducing the use of all types of nicotine products.


She said, "We need to consider reducing the use of combustible cigarettes as our primary objective and limit or stop overall public health strategies for all teenagers using nicotine products.


Statement:


This article is compiled from third-party information and is intended for industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is only intended for industry research and communication purposes.


Due to limitations in the level of translation, the compiled article may not accurately reflect the original text. Please refer to the original article for accuracy.


Regarding any domestic, Hong Kong, Macao, Taiwan, or foreign-related expressions and positions, 2FIRSTS maintains complete alignment with the Chinese government.


Translation: The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives
Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
JTI Korea launched the Ploom AURA Teal Electric Pop limited edition in South Korea on September 1, 2026, marking the first dual-color design in the Ploom AURA range. The device combines a dark green body with teal accents and is accompanied by matching Front Panel, Back Cover and Pocket Bag accessories. The standalone device is priced at KRW 29,000, with three additional device-and-accessory bundles available. The release continues JTI Korea's use of limited colorways and interchangeable accessories to expand the Ploom AURA portfolio without introducing a new hardware platform.
Sep.03
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09